WST
$320.88
Revenue | $746.9Mn |
Net Profits | $136Mn |
Net Profit Margins | 18.21% |
West Pharmaceutical Services Inc’s revenue fell -0.07% since last year same period to $746.9Mn in the Q3 2024. On a quarterly growth basis, West Pharmaceutical Services Inc has generated 6.4% jump in its revenue since last 3-months.
West Pharmaceutical Services Inc’s net profit fell -15.69% since last year same period to $136Mn in the Q3 2024. On a quarterly growth basis, West Pharmaceutical Services Inc has generated 22.19% jump in its net profits since last 3-months.
West Pharmaceutical Services Inc’s net profit margin fell -15.63% since last year same period to 18.21% in the Q3 2024. On a quarterly growth basis, West Pharmaceutical Services Inc has generated 14.85% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 1.5 |
EPS Estimate Current Year | 1.5 |
West Pharmaceutical Services Inc’s earning per share (EPS) estimates for the current quarter stand at 1.5 - a -13.79% fall from last quarter’s estimates.
West Pharmaceutical Services Inc’s earning per share (EPS) estimates for the current year stand at 1.5.
Earning Per Share (EPS) | 1.85 |
Dividend Per Share (DPS) | 0.2 |
West Pharmaceutical Services Inc’s earning per share (EPS) fell -14.35% since last year same period to 1.85 in the Q3 2024. This indicates that the West Pharmaceutical Services Inc has generated -14.35% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
West Pharmaceutical Services Inc declared 0.2 dividend per share during the earnings announcement for Q3 2024.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-07-25 | 1.74 | 1.52 | -12.64% |
2024-04-25 | 1.26 | 1.56 | 23.81% |
2024-10-24 | 1.5 | 1.85 | 23.33% |